Further research has indicated that the expression of A20 in MG controls Nlrp3 inflammasome activation and CNS inflammation in the EAE mouse model of MS, and the absence of A20 expression in nonessential CNS MФ may also contribute to increased EAE pathology [49, 102]. This evidence concerns the gene NLRP3 and myeloid sarcoma.